Skip to main content
. 2023 Jan 25;10:1115389. doi: 10.3389/fcvm.2023.1115389

Table 1.

Cohort characterization.

Severe acute COVID-19 PIMS
Number of cases n = 7 n = 14
Sex Male 6 (86%) 8 (57%)
Female 1 (14%) 6 (43%)
Age [median] Years 12 12
Risk factors Adipositas (BMI > 30) 4 (57%) 1 (7%)
Pre-existing medical condition 1 (14%) 2 (14%)
Echocardiography Normal 7 (100%)* 14 (100%)
Pathologic (EF, coro, effu, MI) 0 0
Cardiac MRI Nomal 0 7 (50%)
Pathologic 6 (100)** 7 (50%)
ECG Normal 6 (86%) 13 (93%)
Pathologic 1 (14%) 1 (7%)
Clinical symptoms Persistent fever [median duration] 100% [8 days] 100% [8 days]
GI symptoms 1 (14%) 12 (86%)
Rash 0 9 (64%)
Conjunctivitis 0 11 (79%)
Neurolog. symptoms 2 (28%) 4 (29%)
Respiratory symptoms 7 (100%) 10 (71%)
Sore throat 3 (43%) 8 (57%)
Myalgia 0 4 (29)
Swollen hands/feet 0 8 (57%)
Lymphadenopathy 0 8 (57%)
Kawasaki criteria complete na 5 (36%)
HSM 0 10 (71%)

Characteristics of 21 pediatric patients with severe acute COVID-19 or pediatric inflammatory multisystem syndrome (PIMS). BMI, body mass index. Pre-existing medical conditions were Sturge-Weber-syndrome in one patient with acute COVID-19 and two patients in the PIMS group suffering from thalassemia and asthma or B cell leukemia, respectively. Pathologic echocardiography was defined as at least one of the four criteria (1) pericardial effusion, (2) reduced ejection fraction, (3) coronary anomaly, or (4) mitral valve regurgitation.

*

In four patients, due to adiposity, the body surface area was >2 m2 resulting in an inapplicability of pediatric z-scores. All values were normal according to adult criteria and therefore considered normal. MRI, magnetic resonance imaging.

**

No MRI data available in one patient with acute COVID-19. ECG, electrocardiogram; GI, gastrointestinal; Neurolog., neurological, consisting of headache, altered consciousness, meningoencephalitis, and encephalopathy; HSM, hepatosplenomegaly.